Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a

The effects of the selective sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin in low dose on cardiac function were investigated in normoglycemic rats. Cardiac parameters were measured by intracardiac catheterization 30 min after intravenous application of empagliflozin to healthy anima...

Descripción completa

Detalles Bibliográficos
Autores principales: Goerg, Jana, Sommerfeld, Manuela, Greiner, Bettina, Lauer, Dilyara, Seckin, Yasemin, Kulikov, Alexander, Ivkin, Dmitry, Kintscher, Ulrich, Okovityi, Sergey, Kaschina, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196699/
https://www.ncbi.nlm.nih.gov/pubmed/34063987
http://dx.doi.org/10.3390/ijms22115437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196699/
https://www.ncbi.nlm.nih.gov/pubmed/34063987
http://dx.doi.org/10.3390/ijms22115437

Ejemplares similares